Jones Financial Companies
COLL icon

Jones Financial Companies’s Collegium Pharmaceutical COLL Stock Holding History

Jones Financial Companies’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.48K Buy
169
+162
+2,314% +$6.86K ﹤0.01% 3795
2025
Q4 		$324 Hold
7
– – ﹤0.01% 4222
2025
Q3 		$241 Hold
7
– – ﹤0.01% 4113
2025
Q2 		$210 Buy
+7
New +$200 ﹤0.01% 3910
2025
Q1 		– Sell
-4
Closed -$115 – 3739
2024
Q4 		$115 Buy
+4
New +$132 ﹤0.01% 3344

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Jones Financial Companies's COLL Position: Q1 2026 in Review

Jones Financial Companies increased its Collegium Pharmaceutical (COLL) stake by 2,314% in Q1 2026, buying an estimated $6.86K and bringing the position to 169 shares worth $5.48K. The position accounts for ﹤0.01% of the portfolio, ranked #3795.

Jones Financial Companies first reported a position in COLL in Q4 2024 and has held it in 5 quarters since. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Jones Financial Companies held 169 shares of Collegium Pharmaceutical worth $5.48K as of Q1 2026.
  • Jones Financial Companies bought 162 Collegium Pharmaceutical shares in Q1 2026, an estimated $6.86K.
  • Collegium Pharmaceutical made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #3795 holding.
  • Jones Financial Companies first reported a position in Collegium Pharmaceutical in Q4 2024 and has held it in 5 quarters since.
  • 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.